CSNK1A1
| Official symbol: | CSNK1A1 |
| Full name: | casein kinase 1 alpha 1 |
| Location: | 5q32 |
| Also known as: | CK1, CK1a, CKIa, CK1alpha, CKIalpha |
| Entrez ID: | 1452 |
| Ensembl ID: | ENSG00000113712 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.30 | | Gscore (Del): | 0.14 |
|
|
| Recurrently amplified in 1 cancer type(s) | | Recurrently deleted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 5 |
|
|
| Fusions detected in 5 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
CRISPR: COMMON ESSENTIAL
|
|
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 67.58 (Percentile rank: 66.95%) |
| PubTator score: | 73.15 (Percentile rank: 73.58%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
